BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 27046058)

  • 1. T cell factor-4 functions as a co-activator to promote NF-κB-dependent MMP-15 expression in lung carcinoma cells.
    Liu Y; Xu Y; Guo S; Chen H
    Sci Rep; 2016 Apr; 6():24025. PubMed ID: 27046058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A serine in exon 11 determines the full transcriptional activity of TCF-4 in lung carcinoma cells.
    Yang B; Xu Y; Wang X; Liu Y
    Biochem Biophys Res Commun; 2019 Jan; 508(3):675-681. PubMed ID: 30527807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NF-κB potentiates tumor growth by suppressing a novel target LPTS.
    Liu D; Miao H; Zhao Y; Kang X; Shang S; Xiang W; Shi R; Hou A; Wang R; Zhao K; Liu Y; Ma Y; Luo H; Miao H; He F
    Cell Commun Signal; 2017 Oct; 15(1):39. PubMed ID: 29017500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osthole inhibits the invasive ability of human lung adenocarcinoma cells via suppression of NF-κB-mediated matrix metalloproteinase-9 expression.
    Kao SJ; Su JL; Chen CK; Yu MC; Bai KJ; Chang JH; Bien MY; Yang SF; Chien MH
    Toxicol Appl Pharmacol; 2012 May; 261(1):105-15. PubMed ID: 22503731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyaluronan-binding protein 1 (HABP1/p32/gC1qR) induces melanoma cell migration and tumor growth by NF-kappa B dependent MMP-2 activation through integrin α(v)β(3) interaction.
    Prakash M; Kale S; Ghosh I; Kundu GC; Datta K
    Cell Signal; 2011 Oct; 23(10):1563-77. PubMed ID: 21627988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S100A4 regulates migration and invasion in hepatocellular carcinoma HepG2 cells via NF-κB-dependent MMP-9 signal.
    Zhang J; Zhang DL; Jiao XL; Dong Q
    Eur Rev Med Pharmacol Sci; 2013 Sep; 17(17):2372-82. PubMed ID: 24065232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PinX1 serves as a potential prognostic indicator for clear cell renal cell carcinoma and inhibits its invasion and metastasis by suppressing MMP-2 via NF-κB-dependent transcription.
    Li HL; Han L; Chen HR; Meng F; Liu QH; Pan ZQ; Bai J; Zheng JN
    Oncotarget; 2015 Aug; 6(25):21406-20. PubMed ID: 26033551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional upregulation of MT2-MMP in response to hypoxia is promoted by HIF-1α in cancer cells.
    Zhu S; Zhou Y; Wang L; Zhang J; Wu H; Xiong J; Zhang J; Tian Y; Wang C; Wu H
    Mol Carcinog; 2011 Oct; 50(10):770-80. PubMed ID: 21751260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human telomerase reverse transcriptase regulates MMP expression independently of telomerase activity via NF-κB-dependent transcription.
    Ding D; Xi P; Zhou J; Wang M; Cong YS
    FASEB J; 2013 Nov; 27(11):4375-83. PubMed ID: 23884427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CHIP/Stub1 functions as a tumor suppressor and represses NF-κB-mediated signaling in colorectal cancer.
    Wang Y; Ren F; Wang Y; Feng Y; Wang D; Jia B; Qiu Y; Wang S; Yu J; Sung JJ; Xu J; Zeps N; Chang Z
    Carcinogenesis; 2014 May; 35(5):983-91. PubMed ID: 24302614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The host environment promotes the constitutive activation of nuclear factor-kappaB and proinflammatory cytokine expression during metastatic tumor progression of murine squamous cell carcinoma.
    Dong G; Chen Z; Kato T; Van Waes C
    Cancer Res; 1999 Jul; 59(14):3495-504. PubMed ID: 10416616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crosstalk between NF-kappaB/p65 and beta-catenin/TCF4/p300 signalling pathways through alterations in GSK-3beta expression during trans-differentiation of endometrial carcinoma cells.
    Saegusa M; Hashimura M; Kuwata T; Hamano M; Okayasu I
    J Pathol; 2007 Sep; 213(1):35-45. PubMed ID: 17607667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hinokitiol, a tropolone derivative, inhibits mouse melanoma (B16-F10) cell migration and in vivo tumor formation.
    Huang CH; Lu SH; Chang CC; Thomas PA; Jayakumar T; Sheu JR
    Eur J Pharmacol; 2015 Jan; 746():148-57. PubMed ID: 25449038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of matrix metalloproteinase-9 transcription by transforming growth factor-beta is mediated by a nuclear factor-kappaB site.
    Ogawa K; Chen F; Kuang C; Chen Y
    Biochem J; 2004 Jul; 381(Pt 2):413-22. PubMed ID: 15086314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of PMA-induced tumor cell invasion and metastasis by aqueous extract isolated from Prunella vulgaris via the inhibition of NF-kappaB-dependent MMP-9 expression.
    Choi JH; Han EH; Hwang YP; Choi JM; Choi CY; Chung YC; Seo JK; Jeong HG
    Food Chem Toxicol; 2010 Feb; 48(2):564-71. PubMed ID: 19922761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockdown of NF-κB p65 subunit expression suppresses growth of nude mouse lung tumour cell xenografts by inhibition of Bcl-2 apoptotic pathway.
    Qu Y; Qu B; Wang X; Wu R; Zhang X
    Cell Biochem Funct; 2015 Jul; 33(5):320-5. PubMed ID: 26178579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-Myc-interacting protein (NMI) negatively regulates epithelial-mesenchymal transition by inhibiting the acetylation of NF-κB/p65.
    Hou J; Wang T; Xie Q; Deng W; Yang JY; Zhang SQ; Cai JC
    Cancer Lett; 2016 Jun; 376(1):22-33. PubMed ID: 27012186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation of M2 AChR/NF-κB signaling axis reverses epithelial-mesenchymal transition (EMT) and suppresses migration and invasion in non-small cell lung cancer (NSCLC).
    Zhao Q; Yue J; Zhang C; Gu X; Chen H; Xu L
    Oncotarget; 2015 Oct; 6(30):29335-46. PubMed ID: 26336823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential regulation of MMPs by E2F1, Sp1 and NF-kappa B controls the small cell lung cancer invasive phenotype.
    Li Z; Guo Y; Jiang H; Zhang T; Jin C; Young CY; Yuan H
    BMC Cancer; 2014 Apr; 14():276. PubMed ID: 24755270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B cell activating factor (BAFF) gene promoter activity depends upon co-activator, p300.
    Moon EY; Park H
    Immunobiology; 2007; 212(8):637-45. PubMed ID: 17869641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.